Ginkgo Bioworks Holdings has recently seen its fair value price target reaffirmed at $12.00 per share. The discount rate has increased from 8.53% to 9.26% to account for a slightly higher risk profile. Analysts note that while revenue growth forecasts remain stable at about 5.22%, the outlook is shaped by both positive short-term developments and caution over long-term uncertainties. Stay tuned to discover how investors can track these evolving narratives and stay informed about future updates.
Analyst Price Targets don’t always capture the full story. Head over to our Company Report to find new ways to value Ginkgo Bioworks Holdings.
🐂 Bullish Takeaways
-
BTIG raised its price target on Ginkgo Bioworks Holdings to $9 from $6, reflecting increased confidence after a significant second-quarter topline beat.
-
The company’s ability to reduce costs faster than…
